Belgium· BE-AMP-SAM381105-00
Fluomizin 10 mg
A dequalinium product containing dequalinium chloride, registered in Belgium by Gedeon Richter. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Dequalinium is registered in 9 of 19 countries.
Countries holding a registration under ATC G01AC05 (dequalinium), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Dequalinium · ATC G01AC05
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of dequalinium costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dequalinium · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$5.10
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Dequalinium Chloride
- Manufacturer
- Gedeon Richter
- Country
- Belgium (BE)
- ATC code
- G01AC05
- ATC class
- Dequalinium
- Defined daily dose
- 10 mg, V
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb2880789
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dequalinium in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandDonaxylCampusPharma AB
- SwedenDonaxyl 10 mg VaginaltablettCampus Pharma AB
- CanadaVABLYSDUCHESNAY INC
- NorwayDonaxylCampusPharma AB
- PolandFluomizinGedeon Richter Polska Sp. z o.o.
- United KingdomFluomizin 10mg vaginal tabletsGedeon Richter (UK) Ltd
- CzechiaNAXYLVIVAX Pharmaceuticals, s.r.o., Povážská Bystrica
- GermanyDequalinium Chloride RatiopharmRatiopharm Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Fluomizin, Tonsillol
- Bulgaria · Флуомизин
- Czechia · Naxyl
- Germany · Dequalinium Chloride Ratiopharm, Fluomizin
- Estonia · Donaxyl
- Spain · Fluomizin
- Finland · Donaxyl
- France · Vablys
- United Kingdom (Northern Ireland) · Fluomizin
- Croatia · Fluomizin
- Hungary · Fluomizin
- Italy · Coryfin Gola, Dequadin
- Lithuania · Donaxyl
- Luxembourg · Fluomizin
- Latvia · Donaxyl
- Norway · Donaxyl
- Poland · Fluomizin
- Portugal · Fluomizin
- Romania · Fluomizin
- Sweden · Donaxyl
- Slovenia · Fluomizin
- Slovakia · Fluomizin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e63f165a-723a-4a6e-bf7c-747cea8be564 GET /v1/drugs/e63f165a-723a-4a6e-bf7c-747cea8be564?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Vaginal tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Fluomizin 10 mg",
"name_fr": "Fluomizin 10 mg",
"name_nl": "Fluomizin 10 mg",
"amp_code": "SAM381105-00",
"strengths": [
"10.0000",
"653.5000"
],
"pack_count": 1,
"substances": [
"Dequalinium Chloride",
"Lactose Monohydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Dequalinium",
"authorisation_numbers": [
"BE381105"
]
}See everything about dequalinium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.